Boulder, CO · Founded 2014 · Privately Held (backing)
Developer of bio-based chemicals designed for low-cost, sustainable transformation of multiple product markets. DMC Biotechnologies is based in Boulder, CO and was founded in 2014. Its last reported valuation was $104 million in Dec 2021. It has raised $55 million across 6 recorded rounds; the latest was a $1.4 million seed round in Dec 2025.
Last reported valuation
$104.0M
Oct 2026
Priced at
—
Total raised
$55.0M
Last round
Seed Round
Dec 2025
Cap table — not yet on record
DMC Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DMC Biotechnologies with a free account
·The complete investor list: 22 names
·Watch DMC Biotechnologies: the Monday email on marks, rounds and moves
Where does DMC Biotechnologies's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across DMC Biotechnologies's 6 recorded funding rounds.
